Stay updated on BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The notice regarding government funding and operating status was removed from the page, a non-critical informational banner. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:36:04.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the Study Details page for NCT03824405; the core information remains unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:05:53.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T08:25:30.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T05:07:28.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision bumped from v3.0.1 to v3.0.2. No substantive content changes; a minor UI element ('Back to Top') was removed.
    Difference
    0.2%
    Check dated 2025-09-14T23:12:57.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T19:52:10.000Z thumbnail image

Stay in the know with updates to BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.